Zobrazeno 1 - 10
of 10
pro vyhledávání: '"prostate cancer immunotherapy"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sullivan, Camille
Prostate cancer is the second most common cancer in men and the second leading cause of cancer-related deaths in men in the United States, with 191,930 men estimated to be diagnosed with prostate cancer and 33,330 patients expected to succumb to this
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-18 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-18 (2020)
Immunotherapy, by enhancing the endogenous anti-tumor immune responses, is showing promising results for the treatment of numerous cancers refractory to conventional therapies. However, its effectiveness for advanced castration-resistant prostate can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2cb85f215eefbd2bb4b2e040e29c74c
https://doi.org/10.1038/s41598-020-65590-0
https://doi.org/10.1038/s41598-020-65590-0
Autor:
Soha Sadeghi, Donya Altafi, Arvin Haghighatfard, Shabnam Naderifar, Sahel Towfigh Rafiei, Tayebe Talebzade, Ali Dezhgir, Niloofar Ahmadi, Hamed Hojatian
Publikováno v:
Journal of Infection and Molecular Biology. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184d47c71007284a28acbe7fca8c0739
https://doi.org/10.17582/journal.jimb/2018/6.1.1.6
https://doi.org/10.17582/journal.jimb/2018/6.1.1.6
INTRODUCTION AND OBJECTIVES Checkpoint blockade targeting PD-1 or CTLA-4 works by fundamentally different mechanisms (with CTLA-4 inhibition acting at secondary lymphoid organs for activation of naïve T cells, and PD-1 interactions being regulated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::01eb50f75b19f7842654e5fe7a467b78
https://www.bib.irb.hr/1192040
https://www.bib.irb.hr/1192040
Autor:
Benjamin Benzon, George (Shuang) Zhao, Michael Haffner, Mandeep Takhar, Nicholas Erho, Kasra Yousefi, Paula Hurley, Jennifer Bishop, Jeffrey Tosoian, Kamyar Ghabili, Mohammed Alshalalfa, Stephanie Glavaris, Brian Simons, Phuoc Tran, Elai Davicioni, R. Jeffrey Karnes, Edward Schaeffer, Charles Drake, Felix Feng, Ashley Ross
INTRODUCTION AND OBJECTIVES B7-H3 (CD276), part of the B7 superfamily, has been shown to play an immunomodulatory role, however its regulation, receptor and mechanism of action remain unclear. Protein levels of B7-H3 have been previously shown to rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a948eca6db1bc13972155af2f0a640
https://www.bib.irb.hr/1192043
https://www.bib.irb.hr/1192043
Autor:
Jeffrey J. Tosoian, Charles G. Drake, Ashley E. Ross, Phuoc T. Tran, Nicholas Erho, Benjamin Benzon, Felix Y. Feng, Elai Davicioni, Brian W. Simons, M. Takhar, Jeffrey Karnes, Michael C. Haffner, Mohammed Alshalalfa, Edward M. Schaeffer, Paula J. Hurley, Stephanie Glavaris, Shuang G. Zhao
Publikováno v:
ResearcherID
INTRODUCTION AND OBJECTIVES B7-H3 (CD276), part of the B7 superfamily, has been shown to play an immunomodulatory role, however its regulation, receptor and mechanism of action remain unclear. Protein levels of B7-H3 have been previously shown to rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6142f70287ed4f818dab2baf02afc96
https://doi.org/10.1200/jco.2016.34.2_suppl.256
https://doi.org/10.1200/jco.2016.34.2_suppl.256
Autor:
M. D'Asaro, Alfredo Salerno, Serena Meraviglia, Giuseppe Cicero, David Vermijlen, Fabio Fulfaro, Nicola Gebbia, Simona Buccheri, Andrew Roberts, Nadia Caccamo, Adrian Hayday, Francesco Dieli, Matthias Eberl
The increasing evidence that γδ T cells have potent antitumor activity suggests their value in immunotherapy, particularly in areas of unmet need such as metastatic carcinoma. To this end, we initiated a phase I clinical trial in metastatic hormone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39be25c98931cf184aebbdee2ea775c
http://hdl.handle.net/10447/27531
http://hdl.handle.net/10447/27531
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liu J; Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China ., Li WP; Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China ., Yang SJ; Department of Urology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China .
Publikováno v:
Zhonghua nan ke xue = National journal of andrology [Zhonghua Nan Ke Xue] 2022 Apr; Vol. 28 (4), pp. 349-355.